Shabiha Afroj Heeamoni
Role not yet determined Is this you? Add your title
Also affiliated: University of Dhaka (2024–2025)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Shabiha Afroj Heeamoni's research focuses on understanding gene regulation and its implications in cancer, particularly bladder cancer. Her work investigates the roles of splicing factors, such as SRSF6 and SRSF1, in generating specific protein isoforms, like a Wnt-sensitive MuSK isoform. She also studies the oncogenic splicing activity of Enhancer of Zeste Homolog 2 (EZH2) and explores potential therapeutic strategies, including antisense oligonucleotide correction. Heeamoni's research extends to the impact of TP53 gene mutations on gene expression and patient survival in bladder cancer. She has also identified prognostic signatures associated with the epithelial-mesenchymal transition pathway in bladder cancer using TCGA database analysis. Her recent publications include work on targeting EZH2 oncogenic splicing, CRISPR-mediated correction of oncogenic AS-NMD, and the prognostic significance of the TP53 gene in bladder cancer.
Metrics
- h-index: 1
- Publications: 6
- Citations: 7
Selected Publications
-
Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction (2026)
-
CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer (2026)
-
Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction (2026)
-
SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform (2025)
Collaboration Network
Top Collaborators
- SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform
- SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform
- SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
Similar Researchers
Based on overlapping research topics